text zoom
One important question in angiogenesis research is: for how long should inhibition of various pro-angiogenic factors be maintained? As preclinical evidence now suggests, because the VEGF ligand is genetically stable and continuously expressed, it can potentially be targeted throughout tumor development. This section explores the rationale for continued VEGF inhibition, including what happens when VEGF inhibition is withdrawn.
